Lv0
0 积分 2026-08-10 加入
Respiratory syncytial virus infections in adults: a narrative review
1小时前
已完结
Anti-interleukin-4 receptor therapy for COPD with dupilumab?
1小时前
已关闭
A new era in the treatment of acute exacerbations of asthma and COPD
1小时前
已完结
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
1小时前
已完结
Associations between life-course FEV1/FVC trajectories and respiratory symptoms up to middle age: analysis of data from two prospective cohort studies
1小时前
已完结
GOLD COPD report: 2025 update
1小时前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
1小时前
已完结
Evaluating tezepelumab for COPD: a missed target or unmet potential?
1小时前
已完结
Targeting pathogen adhesion molecules to improve COPD outcomes
2小时前
已完结
皖公网安备34019202002308
